Although the response to MT maneuvers at the molecular level is clear, for example, the tolerance associated marker ILT3, which could benefit autoimmune diseases [55], appears to be induced by medium load pressure treatments [40], and many miRNAs respond to certain compressive loads [46], the current paucity of information limits the potential value of adapting MT to particular health problems at present. The gene discussed is LILRB4; the disease is autoimmune disease.